Clinical data of the 13 patients
| Patient | Gender | Age at Onset (years) | Age at Epilepsy (years) | Seizure Frequency | Drug | IQ |
|---|---|---|---|---|---|---|
| 1 | F | 1.5 | 1.1 | 1/month | OXC, VPA, PHB | 86 |
| 2 | M | 1.9 | 0.5 | Free for 1 year | CBZ | 70 |
| 3 | F | 2.5 | No epilepsy | Aspirin | 102 | |
| 4 | F | 2.8 | 1.5 | Free for 8 months | LEV | 76 |
| 5 | F | 8.9 | 0.6 | Free for 8 years | None | 82 |
| 6 | M | 10.3 | No epilepsy | None | 69 | |
| 7 | M | 2.7 | 0.2 | 2/day | OXC | 60 |
| 8 | M | 4.3 | 0.4 | A few per year | OXC | 71 |
| 9 | F | 6.0 | 0.3 | A few per year | OXC | 60 |
| 10 | M | 6.0 | 0.5 | 10–30/day | LEV, VPA | 35 |
| 11 | M | 6.3 | 0.8 | Free for 2 years | CBZ, LEV | 55 |
| 12 | F | 8.1 | 0.3 | Free for 3 years | CBZ | 87 |
| 13 | F | 9.5 | 0.7 | A few per year | CBZ | 60 |
Note:—F indicates female; M, male; OXC, oxcarbamazepine; VPA, valproate; PHB, phenobarbital; LEV, levetiracetam; CBZ, carbamazepine.